CO4940475A1 - Novedosos inhibidores de sulfonamida de la farnesil-protein transferasa - Google Patents

Novedosos inhibidores de sulfonamida de la farnesil-protein transferasa

Info

Publication number
CO4940475A1
CO4940475A1 CO98034142A CO98034142A CO4940475A1 CO 4940475 A1 CO4940475 A1 CO 4940475A1 CO 98034142 A CO98034142 A CO 98034142A CO 98034142 A CO98034142 A CO 98034142A CO 4940475 A1 CO4940475 A1 CO 4940475A1
Authority
CO
Colombia
Prior art keywords
hydrogen
heterocycloalkyl
cycloalkyl
aryl
alkyl
Prior art date
Application number
CO98034142A
Other languages
English (en)
Spanish (es)
Inventor
George F Njoroge
Vibulbhan Bancha
Arthur G Taveras
Ronald J Doll
M Girijavalla Wiyyoor
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO4940475A1 publication Critical patent/CO4940475A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO98034142A 1997-06-17 1998-06-16 Novedosos inhibidores de sulfonamida de la farnesil-protein transferasa CO4940475A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87705097A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
CO4940475A1 true CO4940475A1 (es) 2000-07-24

Family

ID=25369146

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98034142A CO4940475A1 (es) 1997-06-17 1998-06-16 Novedosos inhibidores de sulfonamida de la farnesil-protein transferasa

Country Status (14)

Country Link
EP (1) EP0989980A1 (zh)
JP (1) JP2002507192A (zh)
KR (1) KR20010013826A (zh)
CN (1) CN1267290A (zh)
AR (1) AR012989A1 (zh)
AU (1) AU8253698A (zh)
CA (1) CA2293358C (zh)
CO (1) CO4940475A1 (zh)
HU (1) HUP0004627A2 (zh)
IL (1) IL133393A0 (zh)
NZ (1) NZ501619A (zh)
PE (1) PE86199A1 (zh)
WO (1) WO1998057949A1 (zh)
ZA (1) ZA985218B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689789B2 (en) 1997-06-17 2004-02-10 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US7517884B2 (en) 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7494999B2 (en) 2004-10-29 2009-02-24 Kalypsys, Inc Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
PE20020635A1 (es) * 2000-11-29 2002-07-11 Schering Corp Compuestos triciclicos como inhibidores de la farnesil transferasa
NZ566831A (en) 2005-10-25 2011-09-30 Kalypsys Inc Salts of modulators of PPAR and methods of treating metabolic disorders
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
US9796717B2 (en) * 2013-02-19 2017-10-24 Icahn School Of Medicine At Mount Sinai Tricyclic heterocycles as anticancer agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164717T3 (es) * 1993-10-15 2002-03-01 Schering Corp Compuestos triciclicos de sulfonamida utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas.
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
PE86199A1 (es) 1999-09-24
HUP0004627A2 (hu) 2001-10-28
EP0989980A1 (en) 2000-04-05
CA2293358C (en) 2008-08-05
ZA985218B (en) 1998-12-15
IL133393A0 (en) 2001-04-30
CA2293358A1 (en) 1998-12-23
KR20010013826A (ko) 2001-02-26
NZ501619A (en) 2002-02-01
JP2002507192A (ja) 2002-03-05
WO1998057949A1 (en) 1998-12-23
CN1267290A (zh) 2000-09-20
AU8253698A (en) 1999-01-04
AR012989A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
CO4940458A1 (es) Novedosos inhibidores de urea n-sustituida de transferasa de proteina farnesilo
CO4600634A1 (es) Derivados 6,5-heterobiciclicos sustituidos
ES2162668T3 (es) Derivados de bifenilo o de fenil-piridina sustituidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
TW328089B (en) New azolidinediones as antihyperglycemic agents
CO5540343A2 (es) Derivados de furano y tiofeno que activan receptores activados por el proliferador de la peroxisoma humana
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
CO4940475A1 (es) Novedosos inhibidores de sulfonamida de la farnesil-protein transferasa
NO941080D0 (no) Fluorinerte 17 ater
CO4960656A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol
PE62396A1 (es) Derivado de indol
ES2142773B1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
DK269083D0 (da) Hydroxyalkynyl-azolyl-derivater, fremgangsmade til deres fremstilling samt deres anvendelse som fungicider
AR045007A1 (es) Compuestos de quinazolinona sustituidos con arilamina
CO4700291A1 (es) Compuestos quimicos
ES444913A1 (es) Perfeccionamientos en-o relacionados con compuestos organi- cos.
DE69334206D1 (de) Substituierte hexahydrobenzo(a) phenanthridine
AR054414A1 (es) Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas.
AR122739A1 (es) Derivados de ciclobutil-urea
CO4920224A1 (es) Compuestos de pirrolidinil y pirrolinil etilamina como agonistas kappa
AR002072A1 (es) Proceso para la preparacion de derivados de pirrolidin-2-ona utiles como intermediarios en la sintesis de herbicidas.
ES2171306T3 (es) Compuesto bajo la forma de isomero geometrico puro o de una mezcla de estos isomeros.
ES2194696T3 (es) Compuestos quimicos.
CO4410199A1 (es) Procedimiento estereoselectivo para producir derivados de dihidro-2,3-benzodiacepina
FR2390478A1 (fr) Colorants a radicaux d'alkylsulfonylpyrimidines
CO4700285A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion y su aplciacion en la terapeutica